Nailing a bullous pemphigoid (BP) diagnosis early is even more important now that there is finally a targeted drug approved to treat this disorder: Dupliumab (Dupixent, Sanofi & Regeneron). Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, Founder of the Center for Dermatology NP PA, chats with Donna Culton, MD, PhD, a Professor of Dermatology at the University of North Carolina in Chapel Hill, NC, about the diagnosis and treatment of BP.
